Comparison of the global gene expression of choroid plexus and meninges and associated vasculature under control conditions and after pronounced hyperthermia or amphetamine toxicity

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Bowyer, John F ^a   Patterson, Tucker A ^a   Saini, Upasana T ^a   Hanig, Joseph P ^b   Thomas, Monzy ^a   Camacho, Luísa ^a   George, Nysia I ^a   Chen, James J ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Amphetamines; Cerebral vasculature; Cerebrospinal fluid; Choroid plexus; Gene expression; Hyperthermia; Meninges

Indexed keywords

AMPHETAMINE; MESSENGER RNA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BMP4 GENE; BRAIN REGION; CEREBROSPINAL FLUID; CHOROID PLEXUS; CLDN5 GENE; CONTROLLED STUDY; CORPUS STRIATUM; DIO2 GENE; EPITHELIUM; FCT GENE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; HYPERTHERMIA; LBP GENE; MALE; MENINX; NONHUMAN; NUCLEOTIDE SEQUENCE; OCLN GENE; OXIDATIVE STRESS; PARIETAL CORTEX; RAT; REG3A GENE; REG3B GENE; SCT GENE; SLC15A1 GENE; SOX18 GENE; TIGHT JUNCTION; VASCULARIZATION;

AMPHETAMINE; ARACHNOID; BLOOD-BRAIN BARRIER; BRAIN; CEREBROSPINAL FLUID; CHOROID PLEXUS; ENVIRONMENT; FEVER; HUMANS; MENINGES; TRANSCRIPTOME;

EID: 84874475973     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-147     Document Type: Article

References (68)

1. Praetorius J. Na + -coupled bicarbonate transporters in duodenum, collecting ducts and choroid plexus. J Nephrol 2010, 23(Suppl 16):S35-S42.
2. Burnstock G. Neurogenic control of cerebral circulation. Cephalalgia 1985, 5(Suppl 2):25-33.
3. Hamel E. Perivascular nerves and the regulation of cerebrovascular tone. J Appl Physiol 2006, 100(3):1059-1064.
4. Kulik T, Kusano Y, Aronhime S, Sandler AL, Winn HR. Regulation of cerebral vasculature in normal and ischemic brain. Neuropharmacology 2008, 55(3):281-288. 10.1016/j.neuropharm.2008.04.017, 2896303, 18541276.
5. Papaiconomou C, Bozanovic-Sosic R, Zakharov A, Johnston M. Does neonatal cerebrospinal fluid absorption occur via arachnoid projections or extracranial lymphatics?. Am J Physiol Regul Integr Comp Physiol 2002, 283(4):R869-R876.
6. Johanson CE, Duncan JA, Klinge PM, Brinker T, Stopa EG, Silverberg GD. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res 2008, 5:10. 10.1186/1743-8454-5-10, 2412840, 18479516.
7. Coisne C, Engelhardt B. Tight junctions in brain barriers during central nervous system inflammation. Antioxid Redox Signal 2011, 15:1285-1303. 10.1089/ars.2011.3929, 21338320.
8. Johanson CE, Stopa EG, McMillan PN. The blood-cerebrospinal fluid barrier: structure and functional significance. Methods Mol Biol 2011, 686:101-131. 10.1007/978-1-60761-938-3_4, 21082368.
9. Damkier HH, Brown PD, Praetorius J. Epithelial pathways in choroid plexus electrolyte transport. Physiology (Bethesda) 2010, 25(4):239-249.
10. Owler BK, Pitham T, Wang D. Aquaporins: relevance to cerebrospinal fluid physiology and therapeutic potential in hydrocephalus. Cerebrospinal Fluid Res 2010, 7:15. 10.1186/1743-8454-7-S1-S15, 2949735, 20860832.
11. Bowyer JF, Ali S. High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse 2006, 60(7):521-532. 10.1002/syn.20324, 16952162.
12. Kiyatkin EA, Brown PL, Sharma HS. Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia. Eur J Neurosci 2007, 26(5):1242-1253. 10.1111/j.1460-9568.2007.05741.x, 17767502.
13. Polesskaya O, Silva J, Sanfilippo C, Desrosiers T, Sun A, Shen J, Feng C, Polesskiy A, Deane R, Zlokovic B. Methamphetamine causes sustained depression in cerebral blood flow. Brain Res 2011, 1373:91-100. 3026925, 21156163.
14. Sharma HS, Sjoquist PO, Ali SF. Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51. Curr Pharm Des 2007, 13(18):1903-1923. 10.2174/138161207780858375, 17584116.
15. Ho EL, Josephson SA, Lee HS, Smith WS. Cerebrovascular complications of methamphetamine abuse. Neurocrit Care 2009, 10(3):295-305. 10.1007/s12028-008-9177-5, 19132558.
16. Kalant H, Kalant OJ. Death in amphetamine users: causes and rates. Can Med Assoc J 1975, 112(3):299-304. 1956334, 1089034.
17. McGee SM, McGee DN, McGee MB. Spontaneous intracerebral hemorrhage related to methamphetamine abuse: autopsy findings and clinical correlation. Am J Forensic Med Pathol 2004, 25(4):334-337. 10.1097/01.paf.0000137206.16785.2f, 15577524.
18. Miller MA, Coon TP. Re: Delayed ischemic stroke associated with methamphetamine use. J Emerg Med 2006, 31(3):305-306. author reply 306.
19. Rothrock JF, Rubenstein R, Lyden PD. Ischemic stroke associated with methamphetamine inhalation. Neurology 1988, 38(4):589-592. 10.1212/WNL.38.4.589, 3352918.
20. Abbott NJ, Friedman A. Overview and introduction: the blood-brain barrier in health and disease. Epilepsia 2012, 53(Suppl 6):1-6.
21. Baburamani AA, Ek CJ, Walker DW, Castillo-Melendez M. Vulnerability of the developing brain to hypoxic-ischemic damage: contribution of the cerebral vasculature to injury and repair?. Front Physiol 2012, 3:424. 3493883, 23162470.
22. Caner B, Hou J, Altay O, Fuj M, Zhang JH. Transition of research focus from vasospasm to early brain injury after subarachnoid hemorrhage. J Neurochem 2012, 123(Suppl 2):12-21.
23. Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, Doolittle ND, Engelhardt B, Hallenbeck JM, Lonser RR, Ohlfest JR. Immunologic privilege in the central nervous system and the blood-brain barrier. J Cereb Blood Flow Metab 2013, 33:13-21. 10.1038/jcbfm.2012.153, 23072749.
24. Thomas M, George NI, Patterson TA, Bowyer JF. Amphetamine and environmentally induced hyperthermia differentially alter the expression of genes regulating vascular tone and angiogenesis in the meninges and associated vasculature. Synapse 2009, 63(10):881-894. 10.1002/syn.20661, 19582783.
25. Thomas M, George NI, Saini UT, Patterson TA, Hanig JP, Bowyer JF. Endoplasmic reticulum stress responses differ in meninges and associated vasculature, striatum, and parietal cortex after a neurotoxic amphetamine exposure. Synapse 2010, 64(8):579-593. 10.1002/syn.20763, 20340164.
26. Johnston M, Papaiconomou C. Cerebrospinal fluid transport: a lymphatic perspective. News Physiol Sci 2002, 17:227-230.
27. Johnston M, Zakharov A, Koh L, Armstrong D. Subarachnoid injection of Microfil reveals connections between cerebrospinal fluid and nasal lymphatics in the non-human primate. Neuropathol Appl Neurobiol 2005, 31(6):632-640. 10.1111/j.1365-2990.2005.00679.x, 16281912.
28. Johnston M, Zakharov A, Papaiconomou C, Salmasi G, Armstrong D. Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species. Cerebrospinal Fluid Res 2004, 1(1):2. 10.1186/1743-8454-1-2, 546409, 15679948.
29. Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker W, Holson RR. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 1994, 268(3):1571-1580.
30. Bowyer JF, Tank AW, Newport GD, Slikker W, Ali SF, Holson RR. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 1992, 260(2):817-824.
31. Bowyer JF, Thomas MT, Schmued LC, Ali SF. Brain region-specific neurodegenerative profiles showing the relative importance of amphetamine dose, hyperthermia, seizures and the blood-brain barrier. Ann NY Acad Sci 2008, 1139:127-139. 10.1196/annals.1432.005, 18991857.
32. Miller DB, O'Callaghan JP. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6 J mouse. J Pharmacol Exp Ther 1994, 270(2):752-760.
33. O'Callaghan JP, Miller DB. Neurotoxicity profiles of substituted amphetamines in the C57BL/6 J mouse. J Pharmacol Exp Ther 1994, 270(2):741-751.
34. Chen SH, Niu KC, Lin MT. Cerebrovascular dysfunction is an attractive target for therapy in heat stroke. Clin Exp Pharmacol Physiol 2006, 33(8):663-672. 10.1111/j.1440-1681.2006.04429.x, 16895537.
35. Crandall CG, Gonzalez-Alonso J. Cardiovascular function in the heat-stressed human. Acta Physiol (Oxf) 2010, 199(4):407-423.
36. Thulesius O. Thermal reactions of blood vessels in vascular stroke and heatstroke. Med Princ Pract 2006, 15(4):316-321. 10.1159/000092999, 16763403.
37. Kiyatkin EA, Sharma HS. Permeability of the blood-brain barrier depends on brain temperature. Neuroscience 2009, 161(3):926-939. 10.1016/j.neuroscience.2009.04.004, 2694729, 19362131.
38. Chaitanya GV, Eeka P, Munker R, Alexander JS, Babu PP. Role of cytotoxic protease granzyme-b in neuronal degeneration during human stroke. Brain Pathol 2011, 21(1):16-30. 10.1111/j.1750-3639.2010.00426.x, 20825413.
39. Bowyer JF, Thomas M, Patterson TA, George NI, Runnells JA, Levi MS. A visual description of the dissection of the cerebral surface vasculature and associated meninges and the choroid plexus from rat brain. J Vis Exp 2012, 69:e4285. 3523424, 23183685.
40. Lam TI, Wise PM, O'Donnell ME. Cerebral microvascular endothelial cell Na/H exchange: evidence for the presence of NHE1 and NHE2 isoforms and regulation by arginine vasopressin. Am J Physiol Cell Physiol 2009, 297(2):C278-C289. 10.1152/ajpcell.00093.2009, 2724093, 19458287.
41. Friis UG, Madsen K, Svenningsen P, Hansen PB, Gulaveerasingam A, Jorgensen F, Aalkjaer C, Skott O, Jensen BL. Hypotonicity-induced Renin exocytosis from juxtaglomerular cells requires aquaporin-1 and cyclooxygenase-2. J Am Soc Nephrol 2009, 20(10):2154-2161. 10.1681/ASN.2008090944, 2754103, 19628672.
42. Abuladze N, Pushkin A, Tatishchev S, Newman D, Sassani P, Kurtz I. Expression and localization of rat NBC4c in liver and renal uroepithelium. Am J Physiol Cell Physiol 2004, 287(3):C781-C789. 10.1152/ajpcell.00590.2003, 15151908.
43. Xu J, Worrell RT, Li HC, Barone SL, Petrovic S, Amlal H, Soleimani M. Chloride/bicarbonate exchanger SLC26A7 is localized in endosomes in medullary collecting duct cells and is targeted to the basolateral membrane in hypertonicity and potassium depletion. J Am Soc Nephrol 2006, 17(4):956-967. 10.1681/ASN.2005111174, 16524946.
44. Suzuki Y, Yasuoka Y, Shimohama T, Nishikitani M, Nakamura N, Hirose S, Kawahara K. Expression of the K + channel Kir7.1 in the developing rat kidney: role in K + excretion. Kidney Int 2003, 63(3):969-975. 10.1046/j.1523-1755.2003.00806.x, 12631077.
45. Tani T, Gram LK, Arakawa H, Kikuchi A, Chiba M, Ishii Y, Steffansen B, Tamai I. Involvement of organic anion transporting polypeptide 1a5 (Oatp1a5) in the intestinal absorption of endothelin receptor antagonist in rats. Pharm Res 2008, 25(5):1085-1091. 10.1007/s11095-007-9472-4, 17957449.
46. Cockrell E, Espinola RG, McCrae KR. Annexin A2: biology and relevance to the antiphospholipid syndrome. Lupus 2008, 17(10):943-951. 3417102, 18827060.
47. Palha JA, Nissanov J, Fernandes R, Sousa JC, Bertrand L, Dratman MB, Morreale de Escobar G, Gottesman M, Saraiva MJ. Thyroid hormone distribution in the mouse brain: the role of transthyretin. Neuroscience 2002, 113(4):837-847. 10.1016/S0306-4522(02)00228-2, 12182890.
48. Gastardelo TS, Damazo AS, Dalli J, Flower RJ, Perretti M, Oliani SM. Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation. Am J Pathol 2009, 174(1):177-183. 10.2353/ajpath.2009.080342, 2631330, 19095957.
49. Meyer-Siegler KL, Xia SL, Vera PL. Substance P increases cell-surface expression of CD74 (receptor for macrophage migration inhibitory factor): in vivo biotinylation of urothelial cell-surface proteins. Mediators Inflamm 2009, 2009:535348. 2659399, 19325914.
50. Masamune A, Satoh M, Hirabayashi J, Kasai K, Satoh K, Shimosegawa T. Galectin-1 induces chemokine production and proliferation in pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2006, 290(4):G729-G736. 10.1152/ajpgi.00511.2005, 16373424.
51. Palladino MA, Mallonga TA, Mishra MS. Messenger RNA (mRNA) expression for the antimicrobial peptides beta-defensin-1 and beta-defensin-2 in the male rat reproductive tract: beta-defensin-1 mRNA in initial segment and caput epididymidis is regulated by androgens and not bacterial lipopolysaccharides. Biol Reprod 2003, 68(2):509-515.
52. Meuter S, Moser B. Constitutive expression of CXCL14 in healthy human and murine epithelial tissues. Cytokine 2008, 44(2):248-255. 10.1016/j.cyto.2008.08.009, 18809336.
53. Engelhardt B. Development of the blood-brain barrier interface. Blood-brain Barrier Interfaces: From Ontogeny to Artificial Barriers vol. 1 2006, 11-39. Weinheim: Wiley-VCH Verlag GmbH & Co, KGaA, Dermietzel RS DC, Nedergaard M.
54. Morita K, Furuse M, Fujimoto K, Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci U S A 1999, 96(2):511-516. 10.1073/pnas.96.2.511, 15167, 9892664.
55. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003, 161(3):653-660. 10.1083/jcb.200302070, 2172943, 12743111.
56. Furuse M, Tsukita S. Claudins in occluding junctions of humans and flies. Trends Cell Biol 2006, 16(4):181-188. 10.1016/j.tcb.2006.02.006, 16537104.
57. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005, 57(2):173-185. 10.1124/pr.57.2.4, 15914466.
58. Forster C. Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol 2008, 130(1):55-70. 10.1007/s00418-008-0424-9, 2413111, 18415116.
59. Okamoto H. The Reg gene family and Reg proteins: with special attention to the regeneration of pancreatic beta-cells. J Hepatobiliary Pancreat Surg 1999, 6(3):254-262. 10.1007/s005340050115, 10526060.
60. Dummula K, Vinukonda G, Chu P, Xing Y, Hu F, Mailk S, Csiszar A, Chua C, Mouton P, Kayton RJ. Bone morphogenetic protein inhibition promotes neurological recovery after intraventricular hemorrhage. J Neurosci 2011, 31(34):12068-12082. 10.1523/JNEUROSCI.0013-11.2011, 3167068, 21865450.
61. Krasity BC, Troll JV, Weiss JP, McFall-Ngai MJ. LBP/BPI proteins and their relatives: conservation over evolution and roles in mutualism. Biochem Soc Trans 2011, 39(4):1039-1044. 10.1042/BST0391039, 21787344.
62. Di-Gregorio A, Sancho M, Stuckey DW, Crompton LA, Godwin J, Mishina Y, Rodriguez TA. BMP signalling inhibits premature neural differentiation in the mouse embryo. Development 2007, 134(18):3359-3369. 10.1242/dev.005967, 17699604.
63. Dizon ML, Maa T, Kessler JA. The bone morphogenetic protein antagonist noggin protects white matter after perinatal hypoxia-ischemia. Neurobiol Dis 2011, 42(3):318-326. 10.1016/j.nbd.2011.01.023, 3079774, 21310236.
64. Bowyer JF, Peterson SL, Rountree RL, Tor-Agbidye J, Wang GJ. Neuronal degeneration in rat forebrain resulting from D-amphetamine-induced convulsions is dependent on seizure severity and age. Brain Res 1998, 809(1):77-90. 10.1016/S0006-8993(98)00846-4, 9795148.
65. Chomczynski P, Mackey K. Short technical reports. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques 1995, 19(6):942-945.
66. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19(2):185-193. 10.1093/bioinformatics/19.2.185, 12538238.
67. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001, 98(9):5116-5121. 10.1073/pnas.091062498, 33173, 11309499.
68. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995, 57:289-300.